Zuziela Matthew A, Vidal Jennifer, Knorr John P
Einstein Medical Center Philadelphia, PA, USA.
Hosp Pharm. 2021 Aug;56(4):359-367. doi: 10.1177/0018578720906614. Epub 2020 Feb 15.
Shortened allograft survival, and cardiovascular morbidity and mortality are consequences of inadequate control of hypertension for kidney transplant recipients (KTRs). Literature suggests the risk is multifactorial, although few studies have evaluated risk factors in relation to guideline recommended blood pressure (BP) goals in the early post-kidney transplant period. This study will elucidate factors associated with controlled BP in KTRs. Adult KTRs who were transplanted between January 1, 2013, and October 31, 2018, were evaluated. Coprimary outcomes included the proportion of patients who had controlled BP at postoperative day (POD) 30 and identification of the covariates associated with controlled BP at POD 30. Additional outcomes included the proportion of patients who had controlled BP at POD 60 and 90; the difference in the average number of antihypertensive medications taken pretransplant vs POD 30, 60, and 90 for patients with controlled BP at POD 30; antihypertensive use rates pretransplant vs POD 30 and 90; and class of antihypertensive used pretransplant vs POD 30 and 90. At POD 30, 44% (100/226) of patients had controlled BP. The proportion of patients with controlled BP at POD 60 and 90 were 37% (82/220) and 40% (79/196), respectively. In bivariate analyses, lack of recipient hypertension (75% vs 42.5%, = .04); fewer days on dialysis (1684 vs 2189 days, = .005); absence of delayed graft function (51.2% vs 35.6%, = .02); younger donor age (30 vs 40 years, < .001); absence of donor hypertension (46.9% vs 29.3%, = .004); and a lower median kidney donor profile index (29% vs 40%, = .03) were associated with controlled BP at POD 30. In a multivariate analysis, donor age was independently associated with controlled BP at POD 30 ( = .03). This study suggests that younger donor age is associated with controlled BP, and conversely, older donor age is associated with uncontrolled BP in KTRs in the early post-kidney transplant period. Patients receiving a graft from older donors should have their BP closely monitored.
移植肾存活期缩短以及心血管疾病的发病率和死亡率是肾移植受者(KTRs)高血压控制不佳的后果。文献表明,这种风险是多因素的,尽管很少有研究评估肾移植术后早期与指南推荐血压(BP)目标相关的风险因素。本研究将阐明与KTRs血压得到控制相关的因素。对2013年1月1日至2018年10月31日期间接受移植的成年KTRs进行了评估。共同主要结局包括术后第30天血压得到控制的患者比例以及确定与术后第30天血压得到控制相关的协变量。其他结局包括术后第60天和第90天血压得到控制的患者比例;术后第30天血压得到控制的患者移植前与术后第30天、第60天和第90天服用抗高血压药物平均数量的差异;移植前与术后第30天和第90天的抗高血压药物使用率;以及移植前与术后第30天和第90天使用的抗高血压药物类别。在术后第30天,44%(100/226)的患者血压得到控制。术后第60天和第90天血压得到控制的患者比例分别为37%(82/220)和40%(79/196)。在双变量分析中,受者无高血压(75%对42.5%,P = 0.04);透析天数较少(1684天对2189天,P = 0.005);无移植肾功能延迟(51.2%对35.6%,P = 0.02);供者年龄较小(30岁对40岁,P < 0.001);供者无高血压(46.9%对29.3%,P = 0.004);以及较低的中位肾脏供者概况指数(29%对40%,P = 0.03)与术后第30天血压得到控制相关。在多变量分析中,供者年龄与术后第30天血压得到控制独立相关(P = 0.03)。本研究表明,在肾移植术后早期,供者年龄较小与KTRs血压得到控制相关,相反,供者年龄较大与KTRs血压未得到控制相关。接受来自年龄较大供者移植肾的患者应密切监测其血压。